Huihao Xu

Dr. Huihao Xu


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2021 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
JCJingwen Cui
Jingwen Cui
WSWanrong Song
Wanrong Song
YJYi-Peng Jin
Yi-Peng Jin
HXHuihao Xu
Huihao Xu
KFKai Fan
Kai Fan
LJLin Jiahao
Lin Jiahao
As one of the conventional treatment methods, acupuncture is an indispensable component of Traditional Chinese Medicine. Currently, acupuncture has been partly accepted throughout the world, but the mechanism of acupuncture is still unclear. Since the theory of the neuro-endocrine-immune network was put forward, new insights have been brought into the understanding of the mechanism of acupuncture. Studies have proven that acupuncture is a mechanical stimulus that can activate local cell functions and neuroreceptors. It also regulates the release of related biomolecules (peptide hormones, lipid hormones, neuromodulators and neurotransmitters, and other small and large biomolecules) in the microenvironment, where they can affect each other and further activate the neuroendocrine-immune network to achieve holistic regulation. Recently, growing efforts have been made in the research on the mechanism of acupuncture. Some researchers have transitioned from studying the mechanism of acupuncture as a single linear pathway to using systems approaches, including metabolomics, genomics, proteomics and biological pathway analysis. This review summarizes the research progress on the neuro-endocrine-immune network related mechanism of acupuncture and discusses its current challenges and future directions.

13 April 2022 in Animals
Verified
Journal Article
Open access
PDF file
HXHuihao Xu
Huihao Xu
JSJohn S. Sapienza
John S. Sapienza
YJYipeng Jin
Yipeng Jin
LJLin Jiahao
Lin Jiahao
XZXiaobo Zheng
Xiaobo Zheng
DLDegui Lin
Degui Lin
To retrospectively evaluate the effectiveness and outcome of lamellar keratoplasty using acellular bioengineering cornea (BioCorneaVetTM) for the treatment of feline corneal sequestrum (FCS). The medical records of cats diagnosed with FCS that underwent lamellar keratoplasty with BioCorneaVetTM between 2018 and 2021 with a minimum of 3 months of follow-up were reviewed. Follow-up examinations were performed weekly for 3 months, and then optical coherence tomography (OCT) examination was performed on select patients at 0, 3, 6, and 12 months post-operatively. A total of 61 cats (30 left eyes and 32 right eyes) were included. The Persian breed was overrepresented, 48/61 (78.69%). Four different thicknesses of acellular bioengineering cornea were used (200, 300, 400, or 450 microns), and the mean graft size was 8.23 mm (range, 5.00–12.00 mm). Minor complications were composed of partial dehiscence, and protrusion of the graft occurred in 7/62 eyes (11.29%). The median postoperative follow-up was 12.00 months (range, 3–41 months). A good visual outcome was achieved in 60/62 eyes (96.77%), and a mild to moderate corneal opacification occurred in 2/62 (3.23%). No recurrence of corneal sequestrum was observed. From the results, lamellar keratoplasty using acellular bioengineering cornea (BioCorneaVetTM) is an effective treatment for FCS, providing a good tectonic support and natural collagen framework, and resulting in satisfactory visual and cosmetic effects.

23 April 2021 in Archives Animal Breeding
Verified
Journal Article
Open access
PDF file
YHYang Heng
Yang Heng
LFLin Fu
Lin Fu
QLQifeng Luo
Qifeng Luo
LLLicai Li
Licai Li
FZFangling Zheng
Fangling Zheng
HXHuihao Xu
Huihao Xu
MicroRNAs (miRNAs) are widely expressed in different mammalian tissues and exert their biological effects through corresponding target genes. miRNA target genes can be rapidly and efficiently identified and screened by combining bioinformatics prediction and experimental validation. To investigate the possible molecular regulatory mechanisms involving miRNAs during uterine involution in postpartum ewes, we used Illumina HiSeq sequencing technology to screen for the number and characteristics of miRNAs in faster uterine involution and normal uterine involution group. A total of 118 differentially expressed miRNAs, including 33 known miRNAs and 85 new miRNAs, were identified in the hypothalamic library, whereas 54 miRNAs, including 5 known miRNAs and 49 new miRNAs, were identified in the uterine library. Screening with four types of gene prediction software revealed 73 target genes associated with uterine involution, and subsequently, GO annotation and KEGG pathway analysis were performed. The results showed that, in the hypothalamic–uterine axis, uterine involution in postpartum ewes might primarily involve two miRNA-target gene pairs, namely, miRNA-200a–PTEN and miRNA-133–FGFR1, which can participate in GnRH signal transduction in the upstream hypothalamus and in the remodeling process at the downstream uterus, through the PI3K–AKT signaling pathway to influence the recovery of the morphology and functions of the uterus during the postpartum period in sheep. Therefore, identification of differentially expressed miRNAs in this study fills a gap in the research related to miRNAs in uterine involution in postpartum ewes and provides an important reference point for a comprehensive understanding of the molecular mechanisms underlying the regulation of postpartum uterine involution in female livestock.

23 August 2026 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
CHCan Huang
Can Huang
XHXiaoyan Hu
Xiaoyan Hu
YPYunying Peng
Yunying Peng
XPXueling Piao
Xueling Piao
XTXuanrui Tao
Xuanrui Tao
HXHuihao Xu
Huihao Xu
Amniotic membranes are extensively used in feline corneal repair; however, challenges such as rapid degradation and difficulties with preservation across species limit their clinical use. The aim of this study was to develop a feline amniotic membrane-based graft with stem cell activity and provide experimental evidence for its potential use as a corneal epithelial transplant material in cats. FLSCs were first treated with different concentrations of epidermal growth factor (EGF), and 0.5 mg/L EGF was identified as the optimal concentration for promoting cellular activity. Under this condition, FLSCs exhibited enhanced proliferation and wound closure ability, with complete scratch closure observed approximately 24 h earlier than that in the control group. Growth curve analysis showed that FLSCs maintained stable proliferation characteristics, with a calculated population doubling time of approximately 25.2 h. Subsequently, FLSCs were seeded onto the lyophilized feline amniotic membrane scaffold. Light microscopy, scanning electron microscopy, and transmission electron microscopy demonstrated that FLSCs adhered to and proliferated on the scaffold, forming cell–matrix interaction structures, including hemidesmosome-like junctions. Immunofluorescence staining confirmed the expression of stem cell-associated markers ABCG2 and p63 after scaffold culture. These findings demonstrate the successful fabrication of a feline FLSC-loaded amniotic membrane construct in which FLSCs retained the expression of the examined limbal/stem cell-associated markers after scaffold culture. The successfully constructed FLSC-loaded feline amniotic membrane graft demonstrated considerable potential as a novel bioengineered tissue substitute for corneal surface transplantation in clinical applications.